A half-price version of Eli Lilly's popular Humalog insulin is now on sale, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of soaring prices ...

SaveHealth reports that insulin therapy is crucial for diabetes management, with various options available, including rapid- ...

(AP) --A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism of ...

Drugmaker Eli Lilly said Wednesday it would slash prices on several insulin formulations by 70% and expand eligibility for a monthly price cap. The move came as federal pressure mounted on the ...

Eli Lilly & Company LLY announced plans to launch lower-priced versions of two of its insulin product, Humalog – Humalog Mix75/25 KwikPen and Humalog Junior KwikPen. The list price of these low-priced ...

LOS ANGELES - A half-price version of Eli Lilly's popular Humalog insulin is now available, following the company's promise in March to offer diabetics a more affordable option amid fierce criticism ...

Consumer Reports has no financial relationship with advertisers on this site. Faced with skyrocketing costs for insulin to treat his type 1 diabetes and limited insurance options, earlier this month ...

INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

INDIANAPOLIS, June 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Lyumjev ™ (insulin lispro-aabc injection, 100 units/mL and 200 units/mL), Eli Lilly and Company's ...

The list price is $137.35 per vial. This story is from Kaiser Health News When Erin Gilmer filled her insulin prescription at a Denver-area Walgreens in January, she paid $8.50. U.S. taxpayers paid ...

A cheaper generic version of the rapid-acting insulin Humalog has hit the market, according to a statement Wednesday by drugmaker Eli Lilly. The company announced its plans in March amid growing ...